Resmed (RSMDF) Accounts Payables (2010 - 2026)

Resmed (RSMDF) has reported Accounts Payables for 17 consecutive years, with $308.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 11.06% year-over-year to $308.9 million; the trailing twelve-month figure through Jun 2026 stood at $308.9 million (up 11.06% YoY), and the FY2026 full-year result was $308.9 million, up 11.06% from the prior year.
• Accounts Payables improved to $308.9 million in Q2 2026 per RSMDF's latest filing, from $273.3 million in the prior quarter.
• Across five years, Accounts Payables topped out at $308.9 million in Q2 2026 and bottomed at $149.8 million in Q1 2022.
• Historically, Accounts Payables has averaged $214.6 million across 5 years, with a median of $211.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables fell 5.33% in 2023, then jumped 57.69% in 2024.
• Over 5 years, Accounts Payables stood at $196.0 million in 2022, then climbed by 3.26% to $202.4 million in 2023, then increased by 8.85% to $220.3 million in 2024, then climbed by 13.66% to $250.4 million in 2025, then advanced by 23.37% to $308.9 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $308.9 million, $273.3 million, and $250.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.